Study on real-world prescription of mirogabalin besilate using the pharmacy claims database
Not Applicable
- Conditions
- Pain
- Registration Number
- JPRN-UMIN000042592
- Lead Sponsor
- DAIICHI SANKYO CO., LTD.
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 12924
Inclusion Criteria
Not provided
Exclusion Criteria
Patients prescribed mirogabalin besilate within 180 days before the first prescription
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method